NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Micron Biomedical

Micron Biomedical

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://www.micronbiomedical.com/

Last Round

Series A

Extension

Jan 16, 2025

Total Funding Raised

$92.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Micron Biomedical is a biopharmaceutical company that develops a proprietary dissolvable microarray patch technology for needle-free delivery of vaccines and therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

microneedle patchdrug deliveryvaccine deliverytransdermal deliverymicroarray patchneedle-free injectionmedical devicebiotechnologycold-chain freeself-administrationthermostable vaccinedrug delivery platformpainless injectionpatch vaccine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Micron Biomedical Comparables

Compare Micron Biomedical with similar companies based on industry and business-model similarity.

Micron Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Micron Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 16, 2025
GrantJan 14, 2025
GrantJan 7, 2025
GrantJan 7, 2025
GrantNov 16, 2023
Series A Extension
May 10, 2023

Key People

Founding team and executive leadership

Devin McAllister

EVP, CTO Co-Founder

Founding Team

Steven Damon

Chief Executive Officer

Executive Team

Micron Biomedical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 31, 2026

    Recognized as highest global priority innovation by VIPS Alliance.

  • Jan 1, 2026

    Named to Fast Company's 2026 World's Most Innovative Companies list.

Micron Biomedical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Micron Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Micron Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range26
Year Founded2014
Last FundingJan 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.